Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07178574Not Yet Recruiting

Polish Version Dyspnea in Amyotrophic Lateral Sclerosis

Role: lead

NCT06668649Recruiting

Polish Version Fatigue Severity Scale

Role: lead

NCT06363981Not ApplicableRecruiting

Multisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression

Role: lead

NCT06371352Not ApplicableRecruiting

Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression

Role: lead

NCT05295498Not ApplicableRecruiting

Analgesic Effect of Accelerated Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain

Role: lead

NCT05861349Completed

Median Nerve Stenosis in Carpal Tunnel Syndrome

Role: lead

NCT03782558Completed

Validation of the Polish Version of the Boston Carpal Tunnel Syndrome Questionnaire

Role: lead

NCT03627416Not ApplicableCompleted

Repetitive Transcranial Magnetic Stimulation as Therapy in Hereditary Spastic Paraplegia and Adrenomyeloneuropathy

Role: lead

All 8 trials loaded